V025-2621 Screening compound: 2-[4-(3-chlorophenyl)-2,5-dioxo-1-(prop-2-en-1-yl)-1H,2H,3H,4H,5H,6H,7H-pyrrolo[3,4-d]pyrimidin-6-yl]-N-(3,4-dimethylphenyl)acetamide

V025-2621 Screening compound: 2-[4-(3-chlorophenyl)-2,5-dioxo-1-(prop-2-en-1-yl)-1H,2H,3H,4H,5H,6H,7H-pyrrolo[3,4-d]pyrimidin-6-yl]-N-(3,4-dimethylphenyl)acetamide
V025-2621 Screening compound: 2-[4-(3-chlorophenyl)-2,5-dioxo-1-(prop-2-en-1-yl)-1H,2H,3H,4H,5H,6H,7H-pyrrolo[3,4-d]pyrimidin-6-yl]-N-(3,4-dimethylphenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-2621
2-[4-(3-chlorophenyl)-2,5-dioxo-1-(prop-2-en-1-yl)-1H,2H,3H,4H,5H,6H,7H-pyrrolo[3,4-d]pyrimidin-6-yl]-N-(3,4-dimethylphenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-2621

Molecular Formula

C25H25ClN4O3 (C25 H25 ClN4 O3)

Compound Name

2-[4-(3-chlorophenyl)-2,5-dioxo-1-(prop-2-en-1-yl)-1H,2H,3H,4H,5H,6H,7H-pyrrolo[3,4-d]pyrimidin-6-yl]-N-(3,4-dimethylphenyl)acetamide

IUPAC name

2-[4-(3-chlorophenyl)-25-dioxo-1-(prop-2-en-1-yl)-1H2H3H4H5H6H7H-pyrrolo[34-d]pyrimidin-6-yl]-N-(34-dimethylphenyl)acetamide

SMILES

Cc(cc1)c(C)cc1NC(CN(CC(N1CC=C)=C2C(c3cccc(Cl)c3)NC1=O)C2=O)=O

InChI

InChI=1S/C25H25ClN4O3/c1-4-10-30-20-13-29(14-21(31)27-19-9-8-15(2)16(3)11-19)24(32)22(20)23(28-25(30)33)17-6-5-7-18(26)12-17/h4-9,11-12,23H,1,10,13-14H2,2-3H3,(H,27,31)(H,28,33)/t23-/m1/s1

InChI Key

USXWXUVCFCNNNO-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD19936492

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.95

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.332

Distribution Coefficient, logD

4.313

Water Solubility, LogSw

-4.53

Polar Surface Area

67.864

Acid Dissociation Constant (pKa)

8.75

Base Dissociation Constant (pKb)

2.64

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.00

V025-2621 in Drug Discovery

Included in Screening Libraries

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal

References: we are preparing a list of scientific research reports with V025-2621 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-2621?
Check Price and Availability of V025-2621, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-2621 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-2621
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-2621
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-2621 available by request